Amova Asset Management Americas, Inc.
Position in CNTN — Canton Strategic Holdings, Inc.
CIK 1480751
NEW YORK, NY
Position in CNTN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$2,381,106
New position
Shares Held
728,167
first reported quarter
Ownership
1.04%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Amova Asset Management Americas, Inc. holds $292,344,100 across 16 Biotechnology names. CNTN ranks #11 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BEAM |
Beam Therapeutics Inc.
|
3,825,585 | $91,163,690 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
1,853,875 | $88,188,833 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
1,973,061 | $25,294,642 | |
| 4 | NRIX |
Nurix Therapeutics, Inc.
|
1,181,146 | $18,307,763 | |
| 5 | ARCT |
Arcturus Therapeutics Holdings Inc.
|
2,288,935 | $17,670,578 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
5,419,221 | $16,637,008 | |
| 7 | PRME |
Prime Medicine, Inc.
|
2,940,793 | $10,233,959 | |
| 8 | BNTX |
BioNTech SE
|
77,694 | $6,905,442 |
All Filings in CNTN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,381,106 | 728,167 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||